Premier Biomedical, Inc. (BIEI)

Premier Biomedical Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Net Income	-0.37	-0.37	-0.4	-3.76	-1.77	-2.6
Depreciation & Amortization	0	0	0	0	0	0
Other Amortization	0.32	0.32	0.37	0.34	0.75	0.18
Stock-Based Compensation	-	-	0.3	0.78	0.11	1.85
Other Operating Activities	-0.35	-0.35	-0.6	2.12	-0.03	0.02
Change in Accounts Receivable	0	0	-0	-0	-	-
Change in Inventory	0.01	0.01	-0.03	-0.08	-	-
Change in Accounts Payable	-0.07	-0.07	-0.1	0.11	0.04	0.07
Change in Other Net Operating Assets	0.11	0.11	0.01	-0.02	0.41	0.02
Operating Cash Flow	-0.34	-0.34	-0.44	-0.51	-0.48	-0.46
Capital Expenditures	-0	-0	-0	-0	-0	-
Investing Cash Flow	-0	-0	-0	-0	-0	-
Short-Term Debt Issued	0.33	0.33	0.3	0.3	0.42	0.4
Total Debt Issued	0.33	0.33	0.3	0.3	0.42	0.4
Short-Term Debt Repaid	-	-	-	-0.03	-0.09	-
Total Debt Repaid	-	-	-	-0.03	-0.09	-
Net Debt Issued (Repaid)	0.33	0.33	0.3	0.27	0.33	0.4
Issuance of Common Stock	-	-	0	0.3	0.15	0
Financing Cash Flow	0.33	0.33	0.45	0.57	0.47	0.4
Miscellaneous Cash Flow Adjustments	-	-	-	-0	-	-
Net Cash Flow	-0.02	-0.02	0	0.06	-0.01	-0.07
Free Cash Flow	-0.35	-0.35	-0.45	-0.51	-0.49	-0.46
Free Cash Flow Margin	-2444.02%	-2444.02%	-1123.02%	-1282.19%	-	-
Free Cash Flow Per Share	-0.01	-0.01	-0.13	-0.26	-0.80	-3.70
Cash Interest Paid	0	0	0	0.01	0.01	-
Levered Free Cash Flow	-0.31	-0.31	-0.63	2.12	0.06	0.65
Unlevered Free Cash Flow	-0.39	-0.39	-0.74	2	-0.18	0.59
Change in Net Working Capital	0.18	0.18	0.6	-2.02	-0.11	-0.23

Source: S&P Capital IQ. Standard template. Financial Sources.